KALV
Price
$11.10
Change
+$0.06 (+0.54%)
Updated
Oct 17 closing price
Capitalization
560.81M
47 days until earnings call
NUVB
Price
$3.41
Change
-$0.22 (-6.06%)
Updated
Oct 17 closing price
Capitalization
1.17B
18 days until earnings call
Interact to see
Advertisement

KALV vs NUVB

Header iconKALV vs NUVB Comparison
Open Charts KALV vs NUVBBanner chart's image
KalVista Pharmaceuticals
Price$11.10
Change+$0.06 (+0.54%)
Volume$1.17M
Capitalization560.81M
Nuvation Bio
Price$3.41
Change-$0.22 (-6.06%)
Volume$5.84M
Capitalization1.17B
KALV vs NUVB Comparison Chart in %
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KALV vs. NUVB commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALV is a Hold and NUVB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (KALV: $11.10 vs. NUVB: $3.41)
Brand notoriety: KALV and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KALV: 104% vs. NUVB: 87%
Market capitalization -- KALV: $560.81M vs. NUVB: $1.17B
KALV [@Biotechnology] is valued at $560.81M. NUVB’s [@Biotechnology] market capitalization is $1.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KALV’s FA Score shows that 0 FA rating(s) are green whileNUVB’s FA Score has 0 green FA rating(s).

  • KALV’s FA Score: 0 green, 5 red.
  • NUVB’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVB is a better buy in the long-term than KALV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALV’s TA Score shows that 5 TA indicator(s) are bullish while NUVB’s TA Score has 3 bullish TA indicator(s).

  • KALV’s TA Score: 5 bullish, 5 bearish.
  • NUVB’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, KALV is a better buy in the short-term than NUVB.

Price Growth

KALV (@Biotechnology) experienced а -3.48% price change this week, while NUVB (@Biotechnology) price change was -8.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

KALV is expected to report earnings on Dec 04, 2025.

NUVB is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($1.17B) has a higher market cap than KALV($561M). KALV YTD gains are higher at: 31.051 vs. NUVB (28.195). KALV has higher annual earnings (EBITDA): -187.27M vs. NUVB (-201.17M). NUVB has more cash in the bank: 608M vs. KALV (191M). KALV has less debt than NUVB: KALV (6.14M) vs NUVB (57.8M). NUVB has higher revenues than KALV: NUVB (14.4M) vs KALV (1.43M).
KALVNUVBKALV / NUVB
Capitalization561M1.17B48%
EBITDA-187.27M-201.17M93%
Gain YTD31.05128.195110%
P/E RatioN/AN/A-
Revenue1.43M14.4M10%
Total Cash191M608M31%
Total Debt6.14M57.8M11%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KALVNUVB
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EIVIX15.090.12
+0.80%
Allspring Special Large Cap Value Inst
PPUPX16.520.09
+0.55%
Principal LargeCap Growth I R5
HWSCX53.780.12
+0.22%
Hotchkis & Wiley Small Cap Value C
WEBAX10.600.02
+0.19%
TETON Westwood Balanced AAA
EMFIX13.67-0.06
-0.44%
Ashmore Emerging Markets Equity Instl

KALV and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALV has been loosely correlated with VRDN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if KALV jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALV
1D Price
Change %
KALV100%
+0.54%
VRDN - KALV
45%
Loosely correlated
+5.22%
COGT - KALV
44%
Loosely correlated
+0.18%
ATXS - KALV
43%
Loosely correlated
-0.91%
NUVB - KALV
43%
Loosely correlated
-6.06%
ERAS - KALV
42%
Loosely correlated
-4.35%
More

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
-6.06%
BEAM - NUVB
48%
Loosely correlated
+0.74%
XNCR - NUVB
47%
Loosely correlated
-1.20%
RCUS - NUVB
47%
Loosely correlated
-0.78%
IDYA - NUVB
46%
Loosely correlated
+5.67%
EYPT - NUVB
46%
Loosely correlated
+0.69%
More